Democrats Need the Green New Deal if They Want the White House: Justice Democrats
*By Chloe Aiello*
The Democratic Party establishment still have a chance to embrace the Green New Deal ー and their success in upcoming elections might just depend on it, Justice Democrats Communications Director Waleed Shahid told Cheddar on Monday.
"I think we've shown that the public is really excited about this, that young people are really excited about this, and going into the 2020 presidential race, candidates would be smart to take this up if they are trying to run for president on the Democratic side," Shahid said.
The Green New Deal is a proposed economic stimulus plan that aims to radically reduce carbon emissions, while also narrowing the income gap in the U.S. Its aggressive climate goals fall in line with recommendations from the United Nations Climate Change Conference and has become a rallying point for progressive Democrats like Alexandria Ocasio-Cortez. The Justice Democrats, a progressive political action committee, is partnering with Ocasio-Cortez and others like the activist Sunrise Movement to push the proposal.
But advocates have been disappointed by the response of the House Democratic leadership, led by Rep. Nancy Pelosi (D-Fla.), who created a select committee on climate change that Shahid called "toothless." Specifically, Shahid criticized Rep. Kathy Castor, who was picked to lead the committee, for sending signals that are "kind of mixed" on the issue of whether members who had accepted donations from the fossil fuel industry could serve on the committee.
"I think they should really seize this opportunity that young people and freshman congresspeople like Alexandria Ocasio-Cortez are providing them," Shahid said. "At the same time, the Democratic party leadership and the Democratic Party establishment never misses an opportunity to miss an opportunity."
Pne Democratic presidential contender is voicing at least tentative support for the proposal. An aide to Sen. Elizabeth Warren, who was the first prominent Democrat to formally explore a presidential run, [told Axios on Sunday](https://www.axios.com/elizabeth-warren-backs-idea-of-green-new-deal-8585d278-ca96-484a-8e22-1f616956c034.html) that Warren broadly supports the "idea" of a Green New Deal.
The movement has been criticized for being too radical, but Shahid said the U.S. has successfully embraced bold policy agendas in the past.
"We can achieve really big things like mobilizing a war economy for WWII that helped create the world's greatest middle class, that helped significantly reduce poverty during the original depression, that created the great society and civil rights legislation ー it is ambitious, but it is literally what the U.N. is asking for," he said.
For full interview [click here](https://cheddar.com/videos/whos-afraid-of-a-green-new-deal).
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
